1. Ashford NA, Miller CS. Chemical exposures: low levels and high stakes. 2nd ed. New York, NY: Wiley; 1998. p. 10–3.
2. Bishop C, Hudson VM, Hilton SC, Wilde C. A pilot study of the effect of inhaled buffered reduced glutathione on the clinical status of patients with cystic fibrosis. Chest. 2005;127:308–17.
3. Blejer HP. Letter to Col. V. L. Carter Chairman of the TLV committee dated 5 June 1980.
4. Board P, Coggan M, Johnston P, Ross V, Suzuki T, Webb G. Genetic heterogeneity of the human glutathione transferases: a complex of gene families. Pharmacol Ther. 1990;48:357–69.
5. Brooks SM, Weiss MA, Bernstein IL. Reactive airways dysfunction syndrome. Case reports of persistent airways hyperreactivity following high-level irritant exposures. J Occup Med. 1985;27:473–6.